Literature DB >> 3669187

Effects of some calcium channel blockers on isolated human penile erectile tissues.

M Fovaeus1, K E Andersson, H Hedlund.   

Abstract

The effects of the calcium channel blockers (CCBs) verapamil, nifedipine and diltiazem on contractile activation of isolated human penile erectile tissues were investigated. Specimens of the corpus spongiosum (CS) and corpora cavernosa (CC) were obtained from men with a history of normal penile erection undergoing cystourethrectomy because of bladder malignancy. Preparations were mounted in organ baths and isometric tension was recorded. Deprivation of extracellular calcium abolished electrically induced contractions in both CS and CC preparations within 15 min.; norepinephrine (NE)-induced contractions were reduced by 90% (CS) and 83% (CC) after 30 min. All the CCBs reduced electrically induced contractions concentration-dependently, nifedipine being the most potent agent. Contractions induced by exogenous NE were depressed by about 50%, whereas high K+ (124 mM) induced responses were abolished. It is concluded that contraction in penile erectile tissues is mediated mainly by neuronally released NE stimulating postjunctional alpha-adrenoceptors. The contraction is highly dependent on extracellular calcium and can partly be inhibited by CCBs. It cannot be excluded that some CCBs injected intracavernosally may be useful for diagnosis and even treatment of erectile dysfunction. However, calcium channel blockade may not be as effective as a therapeutic principle as blockade of alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3669187     DOI: 10.1016/s0022-5347(17)43582-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings.

Authors:  K E Andersson; F Holmquist
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

2.  Cellular mechanisms of nitric oxide-induced relaxation of corporeal smooth muscle in the guinea-pig.

Authors:  Hikaru Hashitani; Hiroyasu Fukuta; Emma J Dickens; Hikaru Suzuki
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

3.  Effects of intracavernous calcium channel blockers in dogs.

Authors:  S Sarikaya; R Aşçi; Z Aybek; A F Yilmaz; R Büyükalpelli; S Yildiz
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues.

Authors:  G J Christ; S Maayani; M Valcic; A Melman
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

5.  Neuroeffector transmission to different layers of smooth muscle in the rat penile bulb.

Authors:  H Hashitani
Journal:  J Physiol       Date:  2000-04-15       Impact factor: 5.182

6.  Interaction between spontaneous and neurally mediated regulation of smooth muscle tone in the rabbit corpus cavernosum.

Authors:  Hikaru Hashitani; Yoshimasa Yanai; Nobuyuki Shirasawa; Tsuyoshi Soji; Akihiro Tomita; Kenjiro Kohri; Hikaru Suzuki
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

7.  Melatonin attenuates alpha-adrenergic-induced contractions by increasing the release of vasoactive intestinal peptide in isolated rat penile bulb.

Authors:  Ercument Olmez; Zehra Kurcer
Journal:  Urol Res       Date:  2003-07-03

8.  Ryanodine-sensitive intracellular Ca2+ stores in isolated rabbit penile erectile tissue.

Authors:  C Sparwasser; P Drescher; R Eckert; P O Madsen
Journal:  Urol Res       Date:  1995

Review 9.  Drug-induced priapism. Its aetiology, incidence and treatment.

Authors:  J E Baños; F Bosch; M Farré
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb

10.  G-proteins in alpha 1-adrenoceptor mediated prostatic smooth muscle contraction.

Authors:  P Drescher; R E Eckert; P O Madsen
Journal:  Urol Res       Date:  1994
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.